Waltham, MA – InnoCentive Inc., the global leader in crowdsourced innovation and software platforms and ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, announced their partnership, that will provide InnoCentive@WorkTM pharmaceutical customers such as AstraZeneca and Eli Lilly, with a chemical editor tool suitable for generating standard chemical structures and molecular manipulations in an intuitive and simplified way.
“Together with ChemAxon we have created the industry leading crowdsourcing solution for chemistry innovation. ChemAxon adds a critical innovators tool for new chemistry design for our Solvers to more easily compete for prizes in this field,” stated Craig Jones, Chairman and CEO of InnoCentive.
“I am very excited about this partnership as crowdsourcing is becoming the next generation approach to problem solving” – said Ferenc Csizmadia, CEO of ChemAxon. “We look forward to bringing more functionality as we extend our relationship with InnoCentive.”
InnoCentive crowdsources innovation solutions from the world’s smartest people, who compete to provide ideas and solutions to important business, social, policy and scientific challenges. Our global network of millions of problem solvers, proven challenge methodology, and cloud-based innovation management platform, help our clients transform their economics of innovation through rapid solution delivery and the development of sustainable open innovation programs. For over a decade, organizations such as Astra Zeneca, Booz Allen Hamilton, Cleveland Clinic, Eli Lilly & Company, NASA, Procter & Gamble, Thomson Reuters, and several government agencies in the U.S. and Europe have partnered with InnoCentive. For more information, visit www.innocentive.com
ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. We focus on active interaction with users and software portability to create powerful, cost-effective cross platform solutions that power modern cheminformatics and chemical communication. The company is privately owned, headquartered in Budapest, with US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.